Cardinal Health (CAH) Expected to Announce Earnings on Thursday

Cardinal Health (NYSE:CAH) is projected to release its earnings data before the market opens on Thursday, January 30th. Analysts expect Cardinal Health to post earnings of $1.74 per share and revenue of $53,904,600.00 billion for the quarter. Cardinal Health has set its FY25 guidance at $7.75-7.90 EPS and its FY 2025 guidance at 7.750-7.900 EPS.Persons that wish to register for the company’s earnings conference call can do so using this link.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The business had revenue of $52.28 billion for the quarter, compared to analyst estimates of $50.90 billion. During the same period in the prior year, the company earned $1.73 EPS. Cardinal Health’s revenue for the quarter was down 4.3% on a year-over-year basis. On average, analysts expect Cardinal Health to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Cardinal Health Stock Performance

Shares of CAH opened at $128.73 on Thursday. The company has a market cap of $31.15 billion, a price-to-earnings ratio of 25.04, a PEG ratio of 1.54 and a beta of 0.63. The stock has a fifty day moving average price of $120.99 and a two-hundred day moving average price of $112.58. Cardinal Health has a 52-week low of $93.17 and a 52-week high of $129.36.

Cardinal Health Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd were paid a $0.5056 dividend. The ex-dividend date was Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.57%. Cardinal Health’s dividend payout ratio (DPR) is presently 39.30%.

Analyst Ratings Changes

A number of equities research analysts have commented on the stock. Morgan Stanley increased their price objective on shares of Cardinal Health from $127.00 to $136.00 and gave the stock an “overweight” rating in a report on Tuesday, December 17th. Bank of America raised shares of Cardinal Health from a “neutral” rating to a “buy” rating and increased their price target for the company from $132.00 to $145.00 in a research note on Monday, January 6th. UBS Group boosted their price objective on shares of Cardinal Health from $134.00 to $139.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. TD Cowen upgraded Cardinal Health from a “hold” rating to a “buy” rating and increased their price objective for the company from $130.00 to $144.00 in a research report on Wednesday, January 8th. Finally, Citigroup boosted their target price on Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research report on Friday, January 10th. Four investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $133.29.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.